NOVOCURE INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies NovoCure Investors of a Class Action Lawsuit and Upcoming Deadline
10 juil. 2023 16h10 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors of NovoCure Limited (“NovoCure” or the “Company”)...